CIRM Funded Clinical Trials

Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

Disease Area:
CIRM Grant:
Award Value:
Trial Sponsor:
University of California, San Francisco
Trial Stage:
Phase 1
Trial Status:
Not yet recruiting
Targeted Enrollment:
9 ID:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website